FDA Investigator Conrad M Guardia
Conrad M Guardia has inspections in 1 countries as of 01 Sep 2023. Conrad M Guardia has collaborated with a combined 1228 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
58
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adrienne J Goodrich Doctor,
Amber G Chung,
Amos C Epps,
Amy C Amaro,
Andrew J Howard,
Andrew T Todd,
Anthony M Criscuolo, Jr,
Billingsley,
Brian R Yaun,
Brooke K Higgins,
Carrie L Doupnik,
Charlean R Butler,
Charles M Kerns, BLT DO,
Charlotte E Wilkins,
Christine M O'leary,
Christopher M Henderson,
Clarice J Ahn,
Collins,
Crystal A Harlan,
David P Rice,
Decima L Washington,
Dianne H Milazzo,
Dirk L Lincoln,
Douglas A Campbell,
Earl Echon,
Emilio Z Azukwu,
Emmanuel A Dimaano, Jr,
Eric L Vangraafeiland,
Erik T Nagaoka,
Esaw,
Gale L Glinecki,
Gifford Whitehurst, Jr,
Hamilton,
Hector J Colon Torres,
Jacqueline Johnson,
Joell A Eifert,
Joey C West,
John Dan,
Johnson,
Karen A Spencer,
Kenneth L Smalls,
La Tasha M Gunter,
Latoya S Oliver Powell,
Laurianne M Montonye,
LCDR Wilfred A Darang,
Lillian C Hsu,
Linda J Eason,
Marc A Jackson, Jr,
Marla A Cassidy,
Mary K Leslie,
Matthew R Mcnew,
Michael S Call,
Pelekakis,
Pratik S Upadhyay, DDC,
Qin Xu,
Sean R Moynihan, MPH,
Sherry L Secrist, BLT DO,
Sierra M Shockley,
Stacey A Priest,
State Agency,
Stephen C Eason,
Susan J Essenmacher,
Sylvia R Dooling,
Tamara N Champion,
Tania E Vizcaino,
Thomas,
Thomas J Hudson,
William A Warnick,
William D Bassett, Jr,
William H Linkroum
Conrad M Guardia's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2012 | EIR | Lou Ann Maes, M.D. - EIR, 2012-04-03 |
April, 2012 | FDA 483 | Lou Ann Maes, M.D. - Form 483, 2012-04-03 |
July, 2016 | FDA 483 | Ashman Distributing Co., Inc. - Form 483, 2016-07-18 |
July, 2016 | EIR | Ashman Distributing Co., Inc. - EIR, 2016-07-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more